Pfizer’s manipulation and misrepresentation of its Phase 2/3 clinical trial date for COVID-19 vaccines for kids under 5 is dishonest and unethical and makes the data functionally useless for making decisions.
On Sunday night, the U.S. Food and Drug Administration (FDA) released its risk-benefit assessment of Pfizer’s Emergency Use Authorization (EUA) application to inject mRNA into kids 6 months to 4 years old.
This application will be voted on at the June 15 meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC).  Click here to tell your members of Congress to oppose EUA of these vaccines for young children. …